Home › Hypoparathyroidism › Texas
Hypoparathyroidism clinical trials in Texas
3 studies for Hypoparathyroidism are looking for participants at sites in Texas.
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
- Calcilytix Therapeutics, Inc., a BridgeBio Company, Investigational Site, El Paso
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Nov 12, 2026 · NCT07805356A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
- Ascendis Pharma Investigational Site, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07081997A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
- MBX Biosciences Investigational Site, Dallas
- MBX Biosciences Investigational Site, Edinburg
- MBX Biosciences Investigational Site, Round Rock
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07699471From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.